A recent boom in psychedelic research has given way to a bumper crop of startups seeking to harness the potential of mind-altering drugs for treating depression, addiction and other conditions.
Read More
Latest News
Fast-fashion giant Shein could be next blockbuster IPO after filing to...
The company was valued at more than $60 billion in May and is expected to become the most valuable China-founded company to go public in the...
